S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 4, 2009-12 ,pp. : 306-317

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Advanced Glycation End Products (AGEs) and their Receptor (RAGE) in Health and Disease Executive Editor: Sho-ichi Yamagishi ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 939-939

Bentham Science Publishers

Access to resources Recommend Favorite

RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease

By Hudson Barry I.   Schmidt Ann Marie  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1079-1086

Springer Publishing Company

Access to resources Recommend Favorite

Insights into ligand pharmacology using receptor-G-protein fusion proteins

By Milligan G.G.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 1, 2000-01 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 487-495

Bentham Science Publishers

Access to resources Recommend Favorite